Coverage

EPM - Talking Point

Dave Taylor discusses how clinical trial and pharmaceutical manufacturers could perhaps do more to mitigate the risks associated with the local language labeling of clinical trial supplies. If companies are to optimize emerging markets, they must adopt a more uniform approach.

Read the Full Article Here